Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Odds

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
The Journal of Infectious Diseases|November 1, 1987
Systemic candidiasis in Spanish heroin addicts: a possible source of infectionJ M Miró, J Puig de la Bellacasa, F C Odds, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection modelsF C Odds, F Van Gerven, A Espinel-Ingroff, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typingF C Odds, A D Davidson, M D Jacobsen, et al.
The EMBO Journal|September 5, 2001
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicansA M Murad, P Leng, M Straffon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.
Clinical Microbiology Reviews|October 5, 2001
Antifungal susceptibility testing: practical aspects and current challengesJ H Rex, M A Pfaller, T J Walsh, et al.
Journal of Clinical Microbiology|March 7, 2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpointsM A Pfaller, D J Diekema, J H Rex, et al.
Journal of Clinical Microbiology|January 1, 1997
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungiA Espinel-Ingroff, M Bartlett, R Bowden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2011
European expert opinion on the management of invasive candidiasis in adultsB J Kullberg, P E Verweij, M Akova, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
The Journal of Infectious Diseases|November 1, 1987
Systemic candidiasis in Spanish heroin addicts: a possible source of infectionJ M Miró, J Puig de la Bellacasa, F C Odds, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection modelsF C Odds, F Van Gerven, A Espinel-Ingroff, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typingF C Odds, A D Davidson, M D Jacobsen, et al.
The EMBO Journal|September 5, 2001
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicansA M Murad, P Leng, M Straffon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.
Clinical Microbiology Reviews|October 5, 2001
Antifungal susceptibility testing: practical aspects and current challengesJ H Rex, M A Pfaller, T J Walsh, et al.
Journal of Clinical Microbiology|March 7, 2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpointsM A Pfaller, D J Diekema, J H Rex, et al.
Journal of Clinical Microbiology|January 1, 1997
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungiA Espinel-Ingroff, M Bartlett, R Bowden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2011
European expert opinion on the management of invasive candidiasis in adultsB J Kullberg, P E Verweij, M Akova, et al.
Pageof 16